Ready to discuss licensing, strategic partnerships and global business opportunities?
From 28 to 30 October, A.forall will be present at CPHI Frankfurt. Ready to discuss licensing, registration and global opportunities across our growing portfolio in Europe, the US and beyond.
As a company fully focused on generics, we’re coming to Frankfurt with one clear ambition: to connect with partners who share our commitment to access, quality and global growth. From licensing and registration to portfolio expansion and strategic partnerships, we’re here to explore new opportunities that drive real impact in Europe, in the US and worldwide.
This year, we significantly expanded our US presence with the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets. This milestone strengthens our portfolio and underlines our commitment to #MakingAffordableMedicinesAvailableToAll.
Want to explore US opportunities? Erik Lazarich and Siddarth Nirmal from our US team will be on site to discuss licensing, partnerships and expansion strategies across the Atlantic.
We look forward to reconnecting with familiar faces and building new relationships that align with our mission and focus.
📍 You’ll find us in Hall 9.2, Stand A40.
📩 Ready to meet? Book your meeting now via CPHI.2025@aforallpharma.com.
Let’s connect. Let’s talk generics. Let’s make it count — at CPHI
